<DOC>
	<DOCNO>NCT00537212</DOCNO>
	<brief_summary>The association psoriasis obesity question physician many year . Studies show risk psoriasis increase people high body mass index , measurement obesity . There case report remission psoriasis gastric bypass surgery . Furthermore , study show certain inflammatory disease ( rheumatoid arthritis ) improve dietary change . The purpose study ass whether low carbohydrate low fat diet helpful treatment psoriasis .</brief_summary>
	<brief_title>Study Effect Diet Overweight Obese Patients With Psoriasis Light Therapy</brief_title>
	<detailed_description>This study involve use diet therapeutic agent subject obesity psoriasis eligible willing undergo phototherapy . Subjects undergoing phototherapy alone compare subject randomize receive phototherapy dietary modification goal weight loss . The primary objective determine success rate weight loss program set psoriasis . Secondary objective include evaluate effect weight loss efficacy narrow band ultraviolet B phototherapy , assess efficacy low carbohydrate low fat diet psoriatic patient .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>1 . Age great 18 2 . PASI score great 10 3 . BMI great 25 4 . Subjects must willing eligible undergo phototherapy 5 . Willing stop psoriasis therapy 1 . History failure respond NBUVB past . 2 . Presence predominantly guttate , erythrodermic , pustular psoriasis skin condition would interfere evaluation effect study . intervention . 3 . Treatment systemic antibiotic , topical steroid ( except groin face ) , topical Vitamin A D analog , ultraviolet B therapy within 2 week study initiation . 4 . Use oral parenteral corticosteroid . 5 . Use appetite suppressant medication know affect appetite weight . 6 . Treatment biologic therapy past 3 month . 7 . History cutaneous malignancy , include squamous cell carcinoma melanoma two basal cell carcinoma , current actinic keratoses atypical mole . 8 . Evidence photosensitivity disorder ( e.g.polymorphous light eruption . 9 . Use investigational drug , systemic psoriasis therapy , psoralen plus ultraviolet A therapy ( PUVA ) within 4 week study drug initiation . 10 . Subjects currently achieve good clinical control psoriasis current therapy . 11 . Concomitant serious illness medical condition may interfere participation study include renal failure , hepatic failure systemic lupus erythematosus . 12 . Subject currently enrol another investigational device drug trial ( ) , may compromise safety data collection . 13 . Any condition judge investigator cause clinical trial detrimental patient . 14 . Subject know pregnant breastfeeding . 15 . Evidence skin condition ( e.g. , eczema ) psoriasis would interfere studyrelated evaluation psoriasis . 16 . History psychiatric disease would interfere patient 's ability comply study protocol . 17 . History noncompliance therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Weight loss</keyword>
	<keyword>diet</keyword>
</DOC>